In VivoBiopharma merger and acquisition value for the fourth quarter of 2024 reached $9.4bn from 34 transactions, 15 of which had disclosed values. At the top was H. Lundbeck’s $2.6bn purchase of publicly tr
Medtech InsightGynesonics, Inc 's Sonata minimally invasive fibroid treatment is available to 50 million more lives than it was in 2019 now that the US Centers for Medicare and Medicaid Services (CMS) has establishe
Medtech InsightCompany Changes BRENNEMAN , Ryan R. To: EyeGate Pharmaceuticals Inc. , CFO (April) From: CYS Investments Inc., SVP, Chief Accounting Officer Phone: 781-788-9043 CHEN , Jiayu, PhD To: Gyneso
In VivoNew At The Helm Company Changes ANDRE , Patrick, PhD To: Pliant Therapeutics Inc. , VP, Biology (April) From: Merck Sharp & Dohme Corp., Principal Scientist Phone: 650-481-6708 BRENNEMAN , Rya